Alpha,alpha,alpha,alpha&#39;,alpha&#39;,alpha&#39;-hexafluorodi-m-tolylamine derivatives

ABSTRACT

A,A,A,A&#39;&#39;,A&#39;&#39;,A&#39;&#39;-HEXAFLUORODI-M-TOLYMAMINE DERIVATIVES ARE PROVIDED HAVING THE STRUCTURE   R-N(F3C-PHENYL)2   WHEREIN R IS AS DEFINED HEREINAFTER. THESE COMPOUNDS ARE USEFUL AS ANTIBACTERIAL AGENTS AND IN THE TREATMENT OF HYPERENSION.

United States Patent 71,234, now Patent No. 3,712,921, dated Jan. 23, 1973. Divided and this application Oct. 24, 1972, Ser. No.

Int. Cl. C07c 103/10 U.S. Cl. 260-562 P 4 Claims ABSTRACT OF THE DISCLOSURE a,ot,ot,a',a',ot' Hexafluorodi m tolylamine derivatives are provided having the structure wherein R is as defined hereinafter. These compounds are useful as antibacterial agents and in the treatment of hypertension.

This application is a division of copending U.S. application Ser. No. 71,234, filed Sept. 10, 1970 and issued J an. 23, 1973 as U.S. Pat. No. 3,712,921.

The present invention relates to a,a,ot,a',a',a'-heXaliuorodi-m-tolylamine derivatives having the structure 0 ulk.

or lower alkylene-NR R wherein R can be hydrogen, lower alkyl, lower alkoxy, aralkyl, monocyclic cycloalkyl, and monocyclic aryl; R and R can be the same or different and can be hydrogen, lower alkyl, aralkyl, monocyclic cycloalkyl, hydroxy-lower, alkyl, or hydroxy-lower alkoxy-lower alkyl, and R and R can be taken together with the nitrogen to form a 5 to 7 membered monocyclic heterocyclic ring; and to non-toxic acid-addition salts thereof.

The term lower alkyl as employed herein includes both straight and branched chain radicals of up to and including eight carbon atoms, for instance, methyl, ethyl, propyl, isopropyl, butyl, s-butyl, t-butyl, isobutyl, pentyl, hexyl, isohexyl, heptyl, 4,4-dimenthylpentyl, octyl, 2,2,4- trimethylpentyl and the like. The lower alkyl group can include substituents such as aryl.

The term lower alkoxy includes straight and branched chain lower alkyl groups attached to an oxygen.

The term monocyclic aryl as employed herein includes monocyclic carbocyclic aryl radicals, for instance, phenyl and substituted phenyl radicals, including lower alkylphenyl, such as tolyl, ethylphenyl, butylphenyl and the like, di(lower alkyl)phenyl, (e.g., dimethylphenyl, 3,5-diethylphenyl and the like), halophenyl (e.g., chlorophenyl, bromophenyl, and 2,4,5-trichlorophenyl) and nitrophenyl.

The term monocyclic cycloalky includes cyclic radicals containing from 3 to 6 ring members (e.g., cyclopropyl, cyclobutyl, cyclopentyl and. cyclohexyl).

The term lower alkylene encompasses straight chain [(CH where n is 2 to 8] or branched bivalent lower alkyl groups containing from two to eight carbon atoms.

wherein R is 3,830,842 Patented Aug. 20, 1974 Examples of the basic nitrogen containing radical symbolized by the group ice include amino, lower alkylamino, e.g., methylamino, ethylamino, di(lower alkyl)amino, e.g., dimethylamino, diethylamino, dipropylamino, (hydroxy-lower alkyl)amino, e.g., ,B-hydroxyethylamino, di(hydroxy-lower alkyl) amino, e.g., di(hydroxyethyDamino, phenyl(lower alkyl) amino, e.g., benzylamino, and phenethylamino.

As indicated above, the nitrogen may join with the groups represented by R and R to form a 5 to 7 membered monocyclic heterocyclic containing, if desired, an oxygen, sulfur or an additional nitrogen atom (not more than two hetero atoms altogether), that is, the two symbols R and R represent together tetramethylene, pentamethylene, hexamethylene, oxapentamethylene, oxatetramethylene, azahexamethylene, azapentamethylene, azatetramethylene, thiapentamethylene or thiatetramethylene. The heterocyclic group may also be substituted by one or two groups represented by R R or R Illustrative heterocyclic groups include piperidino, e.g., methylpiperidino, di(lower alkyl)piperidino, e.g., dimethylpiperidino, (lower alkoxy)piperidino, e.g., methoxypiperidino, pyrrolidino, (lower alkyl)pyrrolidino, e.g., 2- methylpyrrolidino, di(lower alkyl)pyrrolidino, e.g., 2,5- dimethylpyrrolidino, (lower alkoxy)pyrrolidino, e.g., ethoxypyrrolidino, morpholino, (lower alkyl)morpholi'no, e.g., 3-methylmorpholino or Z-methylmorpholino, di (lower alkyl)morpholino, e.g., 2,3-dimethylmorpholiuo, (lower alkoxy)morpholino, e.g., 2- or 3-ethoxymorpholino, thiamorpholino, (lower a1kyl)thiamorpholino, e.g., 3-methylthiamorpholino or Z-methylthiamorpholino, di (lower alkyl)thiamorpholino, e.g., 2,3-diethylthiamorpholino or 2,3-dimethylthiamorpholino, (lower alkoxy) thiamorpholino, e.g., 2-methoxythiamorpholino, piperazino, (lower alkyl)piperazino, e.g., 4-methylpiperazino, 2-methylpiperazino, di(lower alkyl)piperazino, e.g., 2,3- dimethylpiperazino, hydroxy-lower alkylpiperazino, e.g., 4-(2-hydroxyethyl)piperazino, hexamethyleneimino and homopiperazino.

Preferred are those compounds wherein R is and R and R are alkyl and/ or hydrogen.

Examples of compounds falling within the present in- O can;

((FHQPN N F,c@ @01 .4 l Fae F:

@m l FaC F3 (44) 0 CH: l Ha N F 0 CE;

The compounds of formula I wherein R is and R is hydrogen can be prepared by reacting an a,u,a,a',a,u-hexafluoro-di-tolylamine of the structure Fae CF8 with formic acid at a temperature within the range or from about 80 to about 100 C., in an oxygen-free atmosphere. The amine is employed in a molar ratio to the acid of within the range of from about 0.1 :1 to about 1:1.

The a,cz,a,a',oc',oz'-heXafll10IO di tolylamine is known in the art and can be prepared by the reaction of a halobenzotrifluoride, e.g., m-bromobenzotrifluoride or o-chlO- robenzotrifiuoride, with an acylamidobenzotrifiuoride, e.g., m-acetamidobenzotrifluoride or p-benzamidobenzotrifluoride, in a solvent like nitrobenzene, with powdered anhydrous K CO and a copper catalyst, at 190-2l0, followed by hydrolysis of the N-acyl group.

Compounds of formuIaI wherein R is o y miand R is other than hydrogen can be prepared by acylating an aminobenzotrifluoride of the structure III by reacting it with an acid anhydride of the structure 8 or an acyl halide of the structure (IVA) H R "CHal wherein R is lower alkyl, lower alkoxy, aralkyl, monocyclic cycloalkyl, or monocyclic aryl, and Hal can be Cl, Br, or I, in a molar ratio of aminobenzotrifluoride: acylating agent of within the range of from about 0.1:1 to about 1:1 to form a compound of the structure Compound V is reacted with a halobenzotrifluoride of the structure wherein Hal can be Br, C1 or I in a molar ratio of V:VI of within the range of from about 0.811 to about 1:1 in the presence of anhydrous alkali metal carbonate and copper catalyst and an aprotic solvent such as nitrobenzene, diethylbenzene', diethylacetamide, or dimethylformamide, in an oxygen free atmosphere, at a tempera ture within the range of from about to about 210 C., to form a compound of thestructure 1 meg @01 3 (VIII) Hal-lower alkylene--NR R wherein Hal is Cl, Br or I, in a molar ratio of HzVIII of within the range of from about 0.9:1 to about 1:1, in the presence of an alkali metal halide, such as sodium iodide, in an oxygen-free atmosphere.

Examples of halides of the structure VIII suitable for use in preparing compounds of the invention include the following: dimethylaminoethyl chloride, dimethylaminopropyl chloride, methylethylaminomethyl bromide, ethylisopropylaminobutyl iodide, methylamino-ethyl chloride, aminopropylbromide, methylbenzylaminopentyl chloride, cyclohexylaminoethyl "bromide, hydroxyethylaminohexyl iodide, hydroxyethoxyethylaminopropyl chloride, pyrorolidinoethyl chloride, piperidinopropyl iodide, piperazino- 'butyl chloride, morpholinopentyl bromide, thiamorpholinohexyl iodide as well as alkylene halides containing substituted heterocyclics as indicated hereinbefore.

The bases of formula I form pharmaceutically acceptable acid-addition salts by reaction, with the common inorganic and organic acids. Such inorganic salts as the hydrohalides, e.g., hydrobromide, hydrochloride, hydroiodide, sulfates, nitrates, phosphates, borates, etc., and ar ganic salts as acetate, oxalate,'tartrate, malate, citrate, succinate, benzoate, ascorbate, salicylate, theophyllinate, camphorsulfonate, alkanesulfonate, e.g., methanesulfonate, arylsulfonate, e.g., benzenesulfonate, toluenesulfohate and the like are also within the scope of the invention. It is frequently convenient to effect the purification of the product by forming the acid salt. The base may be ob- 9 tained therefrom by neutralization with an alkali hydroxide such as sodium hydroxide and the base in turn can be transformed into a difierent salt by reaction with the appropriate acid.

The new compounds of this invention have activity upon the central nervous system and are especially active as central nervous system depressants. They may be used as tranquilizers in the alleviation of anxiety and tension states in mammals, e.g., rats, dogs or cats. They may be administered orally or parenterally in the form of tablets, capsules, elixirs, injectables or the like by incorporating the appropriate dosage of the base of formula I or a physiologically acceptable acid addition salt thereof, e.g., about 1 to 50 mg., preferably about 2.5 to 15 mg./kg./per day in two to four divided doses, in a conventional vehicle according to accepted pharmaceutical practice.

Furthermore, the new compounds of formula I are useful as antimicrobial agents and may be used to combat infections in animal species, such as mice, rats, dogs, guinea pigs and the like, due to organisms such as Trichomonas vagin'wlis, T richomonas foetus, Staphyloccocus aureus, Salmonella schottmu'elleri, Klebsiella pneum'oniae, Proteus vulgaris, Escherichia coli, C. albicans or Trichophyton mentagrophytes. For example, a compound or mixture of compounds of formula I or physiologically acceptable acid addition salt or quaternary ammonium salt thereof may be administered orally to an infected animal, e.g., to. a mouse, in an amount of about to 25 mg. per kg. per day' in 2 to 4 divided doses. These may be conventionally formulated in a tablet, capsule or elixir containing about to 250 mg. per dosage unit, by compounding the active substance or substances with the conventional excipient, vehicle, binder, preservative, flavor, etc., as called for by accepted pharmaceutical practice. They may also be applied topically, e.g., to dermatophytosisin a guina pig, in a lotion, salve or cream at a concentration of about 0.01 to 3 percent by weight.

They may also be used as surface disinfectants. About 0.01 to 1 percent by weight of any of these substances may be dispersed on an inert solid or in a liquid such as water and applied as a dust or spray. They may be incorporated also, for example, in a soap or other cleansing agent, e.g., a solid or liquid deteregnt, detergent composition, for example, in general cleaning, in cleaning dairy barns or equipment or cleaning food handling or processing equipment.

The following examples are illustrative of the invention. All temperatures are on the centigrade scale.

EXAMPLE 1 N,N-Bis- (a,u,a-trifluoro-m-tolyl)formamide A solution of 8 g. of a,a,u,a,a',a'-hexafiuoro-di-m- 10 tolylamine in ml, of 98100% formic acid is heated at -100 with stirring, in an atmosphere of nitrogen, for 4 hours. The excess formic acid is removed in vacuo, and the reidue is recrystallized from pentane to give 6.8 g. of N,N,bis-(a,a,a-trifluoro-m-tolyl) :formamide, m.p. about 63-65.

EXAMPLES 2 TO 5 Uing the procedure of Example 1, but replacing the a,ct,a,ot',ot',a' hexafluoro di m tolylamine by there is obtained, respectively EXAMPLE 6 (A) Aceto-m-a,a,a-trifluorotoluidine A saolution of 193.2 g. of m-aminobenzotrifluoride in 3 liters of water and 100 ml. of concd. hydrochloric acid is stirred with ml. of acetic anhydride at room temperature. The reaction becomes exothermic and a granular solid separates from solution. After stirring for 20 minutes the reaction mixture is cooled, and the solid recovered by filtration to give 150.8 g., of aceto-mqaatrifluorotoluidine, m.p. about 103-105 (B N,N-bis a,a,ot-trifluoro-m-tolyl) acetamide A suspension of 152 g. of anhydrous potassium carbonate, 3.5 g. of copper bronze, 225 g. of aceto-m-a,a,atrifiuorotoluidine, and 305 g. of m-bromobenzotrifiuoride in 2 liters of nitrobenzene is heated under reflux, with stirring, in an atmosphere of nitrogen for 22 hours. After cooling, the reaction mixture is filtered, and the filtrate is concentrated in vacua, to give 273 g. of N,N-biS(a,a,cz-trifluoro-m-tolyl)acetamide, m.p. about 73-74.

EXAMPLES 7 TO 18 Using the procedure of Example 6 but substituting the a,a,atrifiuorotoluidine shown in column 1 of Table I below and the acylating agent shown in column 2, and the halo-u,a,a-trifiuorotoluene shown in column 3, the product shown in column 4 is obtained.

TABLE I Column 1 Column 2 Column 3 Column 4 Sample a,az,u-tl'ifltl0r0- Halo-a,a,a-trifiuoro- No. toluldlne Acid anhydride toluene Product 7 F: 02115 O O O C2115 CFs O I \ll H U C C C2Ht NH: Cl

C F; C F:

8 NH CaH1\fi)/O\I)/CaH B a r C O C 1 FC: -0 F: N

13 14 TABLE IContinued Column1 00111111112 00111111113 Column4 Sample a,a,ot-tl'lfll10l0- Ha-a,a,a-lll'lfll10l'0- No. toluidlne Acid anhydrlde toluene Product 18 CF, CH1 CH, CH; I Br or,

0 0 0 NH: 11/ \II/ C- C 0 CF; 2H5 2H5 N 2H5 EXAMPLE 19 recrystallization from 200 ml. of diethyl ether gives 6.6

0 (A) aa,aa',a,a, HexafiuorodLmFtolYlaminc g. of product, m.p. about 65-66 (dec.).

A solution of 271 g. of N,N-bis(a,ot,ot-trlfiu0rO-m-tOlyl) acetamide in 3 liters of 95% ethanol and 800 ml. of concentrated hydrochloric acid is heated under reflux with stirring for 3 hours. The reaction mixture is concentrated in vacuo, the residue is taken up in 600 ml. of ether, washed with 500 ml. of water, then with 100 ml. of 2% sodium hydroxide, and then with water. After drying the solvent is removed by distillation and the residue is fractionated in vacuo to yield 143 g. of u,a,a,a,a',a'-hexafluorodi-m-tolylamine, b.p. about 9498/ 0.2 mm., 11 1.5140.

(B) N,N-Dimethyl-NN'-bis(a,a-trifiuoro-mrtolyl)-1,3-propanediamine A solution of 9 g. of a,11,01,a,a,d-hexafluorodi-wtolylamine in 60 ml. of dimethyl sulfoxide is stirred at room temperature under nitrogen and 2.5 g. (0.05 mole) of sodium hydride (50% in mineral oil) is added in small increments over a period of 45 minutes. The reaction temperature increases spontaneously to 38. Following the addition the reaction temperature is gradually increased to 50. After minutes at 50 the reaction mixture is cooled to 30 and 30- ml. of 2N dimethylaminopropyl chloride in toluene is added followed by 0.5 g. of sodium iodide. The reaction mixture is heated at 6575 for four hours. After cooling to room temperature 7 ml. of ethanol is added. The reaction mixture is poured with stirring into 700 ml. of ice-water. The oil which separates from solution is extracted into 400 ml. of ether. The ethereal solution is washed with water and extracted with 100 ml. of 2.5% hydrochloric acid. The ethereal mother liquor is taken to dryness and triturated with diisopropyl ether to give 10 g. of solid, m.p. 63-65,

EXAMPLE 20 N,N-Dimethyl-N'N-bis(a,a,a-trifluoro-m-tolyl)- ethylene diamine, hydrochloride A solution of 18 g. of a,u,a,a',a,e-hexafluorodi-mtolylamine in 120 ml. of dimethyl sulfoxide is stirred at room temperature under nitrogen and 5 g. of sodium hydride (50% in mineral oil) in added in small increments over a period of 45 minutes. The reaction temperatures increases spontaneously to 38. Following the addition the reaction temperature is gradually increased to 50. After 15 minutes at 50 the reaction mixture is cooled to 30 and "10 g. of dimethylamiuoethyl chloride is added. The reaction mixture is heated -90 for 2 hours. After cooling to room temperature 5 ml. of ethanol is added. The reaction mixture is poured with stirring into 1200 ml. of cold water. The oil which separates from solution is extracted into ether, the solution is washed with water, dried, and the solvent removed. The residue, 19 g., is taken up into 300 ml. of ether. The ethereal solution is extracted with 200 ml. of 2% hydrochloric acid, the ether is dried, filtered, and taken to dryness. The residue of 20.6 g. crystallizes. After trituration with 200 ml. of diisopropyl ether the solid is filtered to give 9 g. of solid, mp. 125 (dec.). It is recrystallized from acetonitrile ether to give 6.3 g. of product, m.p. about 131-133 (dec.).

EXAMPLES 21 TO 45 Using the procedure of Example 19, but substituting the a,0:,11,a',a,u'-hexafluorodi-tolylamine shown in column 1 of Table II below and the aminoalkylene halide shown in column 2 of Table II, the product shown in column 3 is obtained.

TABLE II Column 1 Column 2 Column 3 Example :1 ,a,a,a' ,a' ,a' -H6X8fll10lO-l50ll- No. amine Hal-lower alkylene-NR'R' Product 21 H C H p N CF: a :1 06H" F30 Cl-(CHsh-N (CHflr-N CHI l; H:

FIG 0 F I 22 e lo Ht)a--Nu- C4H| B1-(CH1)1N CF;

TABLE II-Continued Column 1 Column 2 Column 3 Example a, a, a, a, a'a, -Hexafluoro-tolyl- No. amine Hal-lowor alkylene-NRR Product 23 g I(GHq)z-NH: ($1M zNHa 01- CH N CH. )CHI) a-OH C1-CHICH-N CH3 CHz-JIH-CHz-NH:

Bel-lower alkylene-NMB Product Eek (ELK) EXAMPLE 46 with the procedure of Example 6 to give methyl N,N-bis To a solution of 161 g. of mr-aminobenzotrifiuoride and 101 g. of triethylamine in 1.0 l. of dry benzene is added dropwise, with icewater cooling, 94.5 g. of methyl chloro- (a,a,a-trifluoro-m-tolyl)carbamate. 5 EXAMPLE 47 carbonate. Subsequentft'b the addition, the mixture is By-s'ubstituting 161 g. of ovaminobenzotrifluoride for stirred and heated inider reflurgfor one hour, cooled, and (0 'the m-aminobenzotrifiuoride and 122.5 g. of N-propyl filtered from thepr ecipitated triethylamine hydrochloride. chlorocarbonate for the methyl chlorocar-bonate in Ex- The filtrate is concentrated in vacuo to give methyl mample 47, there is obtained n-propyl 0-(oz,cz,u-t1'iflll0l0- (a,a,a-trifluorotolyl)carbamate. tolyl)carbamate which is reacted with a halobenzotri- The methyl m.-(a,a,a-trifluorotolyl)carbamate is then fluoride in accordance with Example 6 to give the above reacted with a m-bromobenzotrifluoride in accordance 75 titled compound.

What is claimed is:

1. A compound of the structure 0 LE I 3. A compound in accordance with claim 1 having the structure I N 5 FaC-@ @CFa 4. A compound in accordance with claim 1 having the structure I CH:

l N namiq or;

References Cited Smith, P. A. et al.: J. Org. Chem, v01. 23, p. 1602,

HENRY R. JILES, Primary Examiner M. A. M. CROWDER, Assistant Examiner US. Cl. X.R. 260557 R, 558 P Patent Column Column Column Column Column Column Inventor-(s) Dated August 20, 1974 Harry Louis Yale It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

line 45, after the words "hydroxy-lower" but before "alkyl, please delete the comma line 54, that portion reading: "4,4-dimenthylpentyl," should be: 4,4-dimethylpentyl, I

line 37, the word "guina" should be: guinea line 1, the word "Sample" should be: Example Example 11, Column 4, the structure should be:

ll COC H Example 14, Column 4, the structure should be:

F ORM PO-105O (O-69) USCOMM-DC 603764 69 & u.s. GOVERNMENT PRINTING OFFICE: Hi9 O3i6-3Jl.-

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent 3,330,342 Dated August 20, 1974 inventm-( Harry Louis Yale It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

Column 13, line 32, that portion of the title of-B reading:

' "bis (oz,oL-trifluorom should be: bis (menu-trifluoro-m- Column 15, Example 25, Column 1, the structure should be:

Column 15, Example 30, Column 1, the structure should be:

Column 18, Example 32, Column 3, the structure should be:

/'CH CH OH (CH N T 2 N F3C cF Column 19, Example 40 Column 2, the structure should be:

N cl- (CH2) 3 N-CHZCHZOH Signed and sealed this 10th day of December 1974.

(SEAL) Attest:

MCCOY M. GIBSON JR. c. MARSHALL DANN Attesting Officer I Commissioner of Patents FORM PO-1050 (10-69) I USCOMM- DC 60376-P09 n U,S. GOVERNMENT PRINTING OFFICE 7 I!" 0-36-33. 

